| Part Of Safety of Arthritis Drugs, Day 3,

Safety of Arthritis Drugs, Day 3, Part 1

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “C… read more

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. Constantine Lyketsos talked about ending a clinical trial because of an apparent link between some uses of “COX-2” inhibitors and heart attacks. Professor Milton Packer showed slides and talked about analyzing cardiac events in research on small samples. Both responded to questions from committee members after their presentations. close

Report Video Issue

People in this video

  • John Cush Chief Presbyterian Hospital (Dallas)->Rheumatology and Immunology
  • Ralph D'Agostino Professor Boston University->Public Health and Statistics
  • John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
  • Thomas Fleming Chairman University of Washington->Biostatistics
  • Curt Furberg Director Wake Forest University->Department of Public Health Services
  • John Jenkins Director U.S. Food and Drug Administration->Office of New Drugs
  • Arthur Levin Director Center for Medical Consumers
  • Constantine Lyketsos M.D. Professor Johns Hopkins Hospital and Health System->Psychiatry
  • Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
  • Robert O'Neil Director U.S. Food and Drug Administration->Biostatistics
  • Milton Packer Professor University of Texas->Southwestern Medical School
  • Steven Shafer M.D. Professor Stanford University->Medical School
  • Robyn Shapiro Professor Medical College of Wisconsin->Bioethics
  • Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
  • Kimberly Topper Executive Secretary U.S. Food and Drug Administration->Center for Drug Evaluation and Research
  • Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 3,

More Videos
More information about

Safety of Arthritis Drugs, Day 3, Part 1

290 Views
Program ID:
185600-1
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 25, 2005 | 9:32am EST | C-SPAN 2

Airing Details

  • Feb 25, 2005 | 9:32am EST | C-SPAN 2
Purchase a Download

Safety of Arthritis Drugs, Day 3, Part 1

  • MP3 audio - Standard
    Price:
    $0.99